“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy

[1]  Francisco M. Olmos-Vega,et al.  A practical guide to reflexivity in qualitative research: AMEE Guide No. 149 , 2022, Medical teacher.

[2]  J. Reis-Filho,et al.  Delivering precision oncology to patients with cancer , 2022, Nature Medicine.

[3]  M. Iddawela,et al.  Personalised cancer care in the era of precision medicine. , 2021, Australian journal of general practice.

[4]  R. Street,et al.  Characterizing patient-oncologist communication in genomic tumor testing: The 21-gene recurrence score as an exemplar. , 2020, Patient education and counseling.

[5]  O. Olopade,et al.  Black Lives Matter Worldwide: Retooling Precision Oncology for True Equity of Cancer Care , 2020, Cell Reports Medicine.

[6]  R. Pratt,et al.  The role of race and ethnicity in views toward and participation in genetic studies and precision medicine research in the United States: A systematic review of qualitative and quantitative studies , 2019, Molecular genetics & genomic medicine.

[7]  E. Hawk,et al.  Mind the Gap: Precision Oncology and Its Potential to Widen Disparities. , 2019, Journal of oncology practice.

[8]  Laura A. Levit,et al.  Implementing Precision Medicine in Community-Based Oncology Programs: Three Models. , 2019, Journal of oncology practice.

[9]  Charles E. Heckler,et al.  Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program , 2018, Journal of Cancer Education.

[10]  Janice L. Krieger,et al.  A Research Agenda for Communication Scholars in the Precision Medicine Era , 2017, Journal of health communication.

[11]  Lang Li,et al.  Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans , 2016, Oncotarget.

[12]  S. Gray,et al.  Quality in the Age of Precision Medicine: The Clinician Perspective. , 2016, Journal of oncology practice.

[13]  Sherri L. LaVela,et al.  Through Their Eyes , 2016, Qualitative health research.

[14]  Christine M. Micheel,et al.  Guiding Oncology Patients Through the Maze of Precision Medicine , 2016, Journal of health communication.

[15]  Dongmei Li,et al.  Sociocultural variation in attitudes toward use of genetic information and participation in genetic research by race in the United States: implications for precision medicine , 2016, J. Am. Medical Informatics Assoc..

[16]  Daniel L. Koller,et al.  Genome-Wide Association Studies for Taxane-Induced Peripheral Neuropathy in ECOG-5103 and ECOG-1199 , 2015, Clinical Cancer Research.

[17]  V. Braun,et al.  What can “thematic analysis” offer health and wellbeing researchers? , 2014, International journal of qualitative studies on health and well-being.

[18]  V. Sheppard,et al.  The role of patient–provider communication for black women making decisions about breast cancer treatment , 2011, Psycho-oncology.

[19]  Karen Patricia Williams,et al.  Development of decision‐support intervention for Black women with breast cancer , 2010, Psycho-oncology.

[20]  N. Leech,et al.  A Qualitative Framework for Collecting and Analyzing Data in Focus Group Research , 2009 .

[21]  Ali Montazeri,et al.  Health-related quality of life in breast cancer patients: A bibliographic review of the literature from 1974 to 2007 , 2008, Journal of experimental & clinical cancer research : CR.

[22]  David Markus.  Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present , 2008 .

[23]  C. Spigner,et al.  Medical Apartheid: The Dark History of Medical Experimentation on Black Americans from Colonial Times to the Present , 2007 .

[24]  Kay Dickersin,et al.  Shaping the future of biomarker research in breast cancer to ensure clinical relevance , 2007, Nature Reviews Cancer.

[25]  V. Braun,et al.  Using thematic analysis in psychology , 2006 .

[26]  Erin M. Goldblatt,et al.  From bench to bedside: the growing use of translational research in cancer medicine. , 2010, American journal of translational research.